查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1957754

2026年全球核糖核酸（RNA）編輯市場報告

Ribonucleic Acid (RNA) Editing Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，核糖核酸（RNA）編輯市場發展迅速。預計該市場規模將從2025年的175.5億美元成長到2026年的190.9億美元，複合年成長率（CAGR）為8.8%。過去幾年推動這一成長的成長要素包括RNA編輯技術的局限性、遺傳疾病發病率的上升趨勢、癌症靶向RNA療法的早期研究、缺乏標準化的編輯通訊協定以及分子生物學領域學術研究的增加。

預計未來幾年核糖核酸（RNA）編輯市場將維持強勁成長，到2030年市場規模將達到264.8億美元，複合年成長率（CAGR）為8.5%。預測期內的成長要素包括RNA介導的Adenosine deaminase（ADAR）編輯技術的開發、精準醫療投資的增加、RNA編輯與基因治療的融合、RNA療法臨床試驗的擴展以及生物技術公司與製藥公司之間合作的加強。預測期內的關鍵趨勢包括傳訊RNA（mRNA）編輯技術的進步、轉移RNA（tRNA）治療應用的發展、核醣體RNA（rRNA）調控研究的拓展、對癌症和遺傳疾病治療日益成長的關注，以及特異性編輯和鹼基編輯技術的應用。

遺傳疾病的日益增多預計將推動核糖核酸（RNA）編輯市場的成長。遺傳疾病是由DNA突變或缺失引起的，這些突變或缺失可能是遺傳自父母，也可能是後天發生的。遺傳疾病的增加與高齡生產有關，因為高齡產婦會增加染色體異常的機率。 RNA編輯透過在不改變DNA的情況下糾正RNA缺陷來解決遺傳疾病，從而確保蛋白質的正常合成。例如，美國疾病管制與預防中心（CDC）在2024年5月估計，鐮狀細胞疾病（SCD）影響10萬美國人。因此，遺傳疾病盛行率的上升正在推動RNA編輯市場的發展。

RNA編輯市場的主要企業正透過體內基因編輯等開創性方法，在活體受試者中實現精準有效的突變矯正。體內基因編輯直接修改活體組織中的基因，以修復缺陷或調節基因表達，以達到治療目的。例如，2024年4月，美國非營利組織雷特症候群研究信託基金成立了MECP2編輯聯盟，匯集了六家頂尖實驗室。該聯盟旨在開發針對雷特氏症根本病因的DNA和RNA編輯技術，並迅速推進臨床試驗。這項合作研究匯集了各機構的專業知識，旨在為嚴重的腦部疾病創造精準且具有潛在治療價值的方案。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球核糖核酸（RNA）編輯市場：吸引力評分與分析
  • 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 清單：主要原料、資源和供應商
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章：全球市場趨勢與策略

  • 關鍵科技與未來趨勢
    • 生物技術、基因組學和精準醫療
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 人工智慧（AI）和自主人工智慧
    • 物聯網、智慧基礎設施、互聯生態系統
  • 主要趨勢
    • 傳訊RNA（mRNA）編輯技術的進展
    • 轉移RNA（tRNA）治療應用技術的發展
    • 拓展對核醣體RNA（rRNA）調控的研究
    • 人們越來越關注癌症和遺傳疾病的治療
    • 採用網站特異性編輯和基礎編輯技術

第5章 終端用戶產業市場分析

  • 生技公司
  • 製藥公司
  • 研究機構
  • 學術研究機構
  • 受託研究機構（CRO）

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球核糖核酸（RNA）編輯市場：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球核糖核酸（RNA）編輯市場規模、比較及成長率分析
  • 全球核糖核酸（RNA）編輯市場表現：規模與成長，2020-2025年
  • 全球核糖核酸（RNA）編輯市場預測：規模與成長，2025-2030年，2035年預測

第8章：全球市場總規模（TAM）

第9章 市場細分

  • 按類型
  • 信使核糖核酸（mRNA）修飾、轉移核糖核酸（tRNA）修飾、核醣體核糖核酸（rRNA）修飾
  • 透過技術
  • 插入或刪除，脫氨基作用
  • 透過使用
  • 癌症、遺傳性疾病、暫時性疾病
  • 依類型細分：信使核糖核酸 (mRNA) 修飾
  • 鹼基編輯，Adenosine deaminase對核糖核酸（RNA）的編輯，位點特異性核糖核酸（RNA）編輯
  • 依類型細分：轉移核糖核酸（RNA）（tRNA）修飾
  • 轉座核糖核酸剪接，肌苷修飾
  • 依類型細分：核醣體核糖核酸 (RNA) (rRNA) 修飾
  • 假尿苷化、核醣體RNA成熟途徑的調控、位點特異性核醣體RNA編輯

第10章 區域與國別分析

  • 全球核糖核酸（RNA）編輯市場：依地區分類，歷史資料及預測，2020-2025年、2025-2030年、2035年
  • 全球核糖核酸（RNA）編輯市場：依國家分類，實際值和預測值，2020-2025年、2025-2030年預測值、2035年預測值

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 核糖核酸（RNA）編輯市場：競爭格局與市場佔有率，2024年
  • 核糖核酸（RNA）編輯市場：公司估值矩陣
  • 核糖核酸（RNA）編輯市場：公司概況
    • Beam Therapeutics Inc.
    • EdiGene Inc.
    • Deep Genomics Incorporated
    • ADARx Pharmaceuticals Inc.
    • Storm Therapeutics Limited

第37章 其他大型企業和創新企業

  • Ascidian Therapeutics Inc., Korro Bio Inc., Shape TX

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：具有高市場潛力的國家、細分市場與策略

  • 2030年核糖核酸（RNA）編輯市場：提供新機會的國家
  • 2030年核糖核酸（RNA）編輯市場：充滿新機會的細分領域
  • 2030年核糖核酸（RNA）編輯市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第41章附錄

簡介目錄
Product Code: PH4MRARE01_G26Q1

Ribonucleic acid (RNA) editing is a post-transcriptional process that modifies the nucleotide sequence of RNA molecules after they are transcribed from deoxyribonucleic acid (DNA). These changes can alter the structure or function of the resulting proteins, impacting gene expression and offering potential therapeutic applications.

The main types of RNA editing include messenger RNA (mRNA) modification, transfer RNA (tRNA) modification, and ribosomal RNA (rRNA) modification. Messenger RNA modification involves chemical alterations to mRNA molecules after transcription, such as methylation or nucleotide sequence editing. Common techniques include insertion, deletion, and deamination. These modifications are applied in areas such as cancer, genetic disorders, and temporary medical conditions.

Tariffs have impacted the RNA editing market by increasing costs of imported gene-editing enzymes, reagents, and laboratory instruments used for mRNA, tRNA, and rRNA modifications. Segments like site-directed RNA editing and base editing technologies are most affected, particularly in regions such as North America and Europe, which rely on imported reagents and specialized equipment. While tariffs have increased operational costs and slowed research supply chains, they have also encouraged local production of reagents, innovation in RNA editing platforms, and investment in domestic biotech capabilities.

The ribonucleic acid (rna) editing market research report is one of a series of new reports from The Business Research Company that provides ribonucleic acid (rna) editing market statistics, including ribonucleic acid (rna) editing industry global market size, regional shares, competitors with a ribonucleic acid (rna) editing market share, detailed ribonucleic acid (rna) editing market segments, market trends and opportunities, and any further data you may need to thrive in the ribonucleic acid (rna) editing industry. This ribonucleic acid (rna) editing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ribonucleic acid (rna) editing market size has grown strongly in recent years. It will grow from $17.55 billion in 2025 to $19.09 billion in 2026 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to limited rna editing technologies, growing prevalence of genetic disorders, early research on cancer-targeted rna therapies, lack of standardized editing protocols, increasing academic research in molecular biology.

The ribonucleic acid (rna) editing market size is expected to see strong growth in the next few years. It will grow to $26.48 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to development of adenosine deaminase acting on rna (adar)-mediated editing, rising investment in precision medicine, integration of rna editing with gene therapy, expansion of clinical trials for rna therapeutics, increasing collaborations between biotech and pharmaceutical companies. Major trends in the forecast period include advancements in messenger rna (mrna) editing technologies, development of transfer rna (trna) therapeutic applications, expansion of ribosomal rna (rrna) modulation research, increasing focus on cancer and genetic disorder treatments, adoption of site-directed and base editing techniques.

The uptick in genetic disorders is anticipated to fuel the ribonucleic acid (RNA) editing market ahead. Genetic disorders arise from DNA alterations or mutations, passed from parents or emerging anew. Their increase ties to older parenthood, elevating odds of chromosomal glitches. Ribonucleic acid (RNA) editing counters genetic disorders by fixing RNA flaws, enabling proper protein output sans DNA changes. For example, in May 2024, the Centers for Disease Control and Prevention (CDC), a US public health body, estimated sickle cell disease (SCD) impacts 100,000 Americans. Thus, the rising genetic disorders are boosting the ribonucleic acid (RNA) editing market.

Prominent companies in the ribonucleic acid (RNA) editing market are pioneering methods like in vivo gene editing for pinpoint, effective mutation fixes in live subjects. In vivo gene editing directly tweaks genes in living tissues to mend flaws or adjust expression for healing. For instance, in April 2024, the Rett Syndrome Research Trust, a US non-profit, formed the MECP2 Editing Consortium uniting six top labs to craft DNA and RNA edits targeting Rett syndrome's root cause, fast-tracking to trials. This teamwork harnesses collective skills for accurate, possibly healing options against the grave brain disorder.

In May 2025, Rznomics Inc., a South Korea biopharma, allied with Eli Lilly and Company to craft and market RNA-editing therapies for sensorineural hearing loss via Rznomics' trans-splicing ribozyme tech-Rznomics leads early research, Lilly late-stage and worldwide launch. Eli Lilly and Company is a US pharma powerhouse backing RNA editing for targeted genetic and rare disease fixes.

Major companies operating in the ribonucleic acid (rna) editing market are Beam Therapeutics Inc., EdiGene Inc., Deep Genomics Incorporated, ADARx Pharmaceuticals Inc., Storm Therapeutics Limited, Ascidian Therapeutics Inc., Korro Bio Inc., Shape TX.

North America was the largest region in the ribonucleic acid (RNA) editing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ribonucleic acid (rna) editing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ribonucleic acid (rna) editing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ribonucleic acid (RNA) editing market consists of revenues earned by entities by providing services such as therapeutic ribonucleic acid (RNA) editing services, ribonucleic acid (RNA) editing delivery optimization, and bioinformatics and data analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The ribonucleic acid (RNA) editing market also includes sales of ribonucleic acid (RNA) editing therapeutics, diagnostic kits, and ribonucleic acid (RNA) editing delivery systems. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ribonucleic Acid (RNA) Editing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses ribonucleic acid (rna) editing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ribonucleic acid (rna) editing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ribonucleic acid (rna) editing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Messenger Ribonucleic Acid (RNA) Modification; Transfer Ribonucleic Acid (RNA) Modification; Ribosomal Ribonucleic Acid (RNA) Modification
  • 2) By Technique: Insertion Or Deletion; Deamination
  • 3) By Application: Cancer; Genetic Disorders; Temporary Maladies
  • Subsegments:
  • 1) By Messenger Ribonucleic Acid(RNA) (Mrna) Modification: Base Editing; Adenosine Deaminase Acting On Ribonucleic Acid (RNA)-Mediated Editing; Site-Directed Ribonucleic Acid (RNA) Editing
  • 2) By Transfer Ribonucleic Acid (RNA) (Trna) Modification: Pseudouridylation; Transfer Ribonucleic Acid Splicing; Inosine Modification
  • 3) By Ribosomal Ribonucleic Acid (RNA) (Rrna) Modification: Pseudouridylation; Ribosomal Ribonucleic Acid (RNA) Maturation Pathway Modulation; Site-Specific Ribosomal Ribonucleic Acid (RNA) Editing
  • Companies Mentioned: Beam Therapeutics Inc.; EdiGene Inc.; Deep Genomics Incorporated; ADARx Pharmaceuticals Inc.; Storm Therapeutics Limited; Ascidian Therapeutics Inc.; Korro Bio Inc.; Shape TX.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Ribonucleic Acid (RNA) Editing Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Ribonucleic Acid (RNA) Editing Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Ribonucleic Acid (RNA) Editing Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Ribonucleic Acid (RNA) Editing Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Advancements In Messenger RNA (mRNA) Editing Technologies
    • 4.2.2 Development Of Transfer RNA (tRNA) Therapeutic Applications
    • 4.2.3 Expansion Of Ribosomal RNA (rRNA) Modulation Research
    • 4.2.4 Increasing Focus On Cancer And Genetic Disorder Treatments
    • 4.2.5 Adoption Of Site-Directed And Base Editing Techniques

5. Ribonucleic Acid (RNA) Editing Market Analysis Of End Use Industries

  • 5.1 Biotechnology Companies
  • 5.2 Pharmaceutical Companies
  • 5.3 Research Institutes
  • 5.4 Academic Laboratories
  • 5.5 Contract Research Organizations (CROs)

6. Ribonucleic Acid (RNA) Editing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Ribonucleic Acid (RNA) Editing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Ribonucleic Acid (RNA) Editing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Ribonucleic Acid (RNA) Editing Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Ribonucleic Acid (RNA) Editing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Ribonucleic Acid (RNA) Editing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Ribonucleic Acid (RNA) Editing Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Ribonucleic Acid (RNA) Editing Market Segmentation

  • 9.1. Global Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Messenger Ribonucleic Acid (RNA) Modification, Transfer Ribonucleic Acid (RNA) Modification, Ribosomal Ribonucleic Acid (RNA) Modification
  • 9.2. Global Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Insertion Or Deletion, Deamination
  • 9.3. Global Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cancer, Genetic Disorders, Temporary Maladies
  • 9.4. Global Ribonucleic Acid (RNA) Editing Market, Sub-Segmentation Of Messenger Ribonucleic Acid(RNA) (Mrna) Modification, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Base Editing, Adenosine Deaminase Acting On Ribonucleic Acid (RNA)-Mediated Editing, Site-Directed Ribonucleic Acid (RNA) Editing
  • 9.5. Global Ribonucleic Acid (RNA) Editing Market, Sub-Segmentation Of Transfer Ribonucleic Acid (RNA) (Trna) Modification, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pseudouridylation, Transfer Ribonucleic Acid Splicing, Inosine Modification
  • 9.6. Global Ribonucleic Acid (RNA) Editing Market, Sub-Segmentation Of Ribosomal Ribonucleic Acid (RNA) (Rrna) Modification, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pseudouridylation, Ribosomal Ribonucleic Acid (RNA) Maturation Pathway Modulation, Site-Specific Ribosomal Ribonucleic Acid (RNA) Editing

10. Ribonucleic Acid (RNA) Editing Market Regional And Country Analysis

  • 10.1. Global Ribonucleic Acid (RNA) Editing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Ribonucleic Acid (RNA) Editing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Ribonucleic Acid (RNA) Editing Market

  • 11.1. Asia-Pacific Ribonucleic Acid (RNA) Editing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Ribonucleic Acid (RNA) Editing Market

  • 12.1. China Ribonucleic Acid (RNA) Editing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Ribonucleic Acid (RNA) Editing Market

  • 13.1. India Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Ribonucleic Acid (RNA) Editing Market

  • 14.1. Japan Ribonucleic Acid (RNA) Editing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Ribonucleic Acid (RNA) Editing Market

  • 15.1. Australia Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Ribonucleic Acid (RNA) Editing Market

  • 16.1. Indonesia Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Ribonucleic Acid (RNA) Editing Market

  • 17.1. South Korea Ribonucleic Acid (RNA) Editing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Ribonucleic Acid (RNA) Editing Market

  • 18.1. Taiwan Ribonucleic Acid (RNA) Editing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Ribonucleic Acid (RNA) Editing Market

  • 19.1. South East Asia Ribonucleic Acid (RNA) Editing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Ribonucleic Acid (RNA) Editing Market

  • 20.1. Western Europe Ribonucleic Acid (RNA) Editing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Ribonucleic Acid (RNA) Editing Market

  • 21.1. UK Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Ribonucleic Acid (RNA) Editing Market

  • 22.1. Germany Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Ribonucleic Acid (RNA) Editing Market

  • 23.1. France Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Ribonucleic Acid (RNA) Editing Market

  • 24.1. Italy Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Ribonucleic Acid (RNA) Editing Market

  • 25.1. Spain Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Ribonucleic Acid (RNA) Editing Market

  • 26.1. Eastern Europe Ribonucleic Acid (RNA) Editing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Ribonucleic Acid (RNA) Editing Market

  • 27.1. Russia Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Ribonucleic Acid (RNA) Editing Market

  • 28.1. North America Ribonucleic Acid (RNA) Editing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Ribonucleic Acid (RNA) Editing Market

  • 29.1. USA Ribonucleic Acid (RNA) Editing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Ribonucleic Acid (RNA) Editing Market

  • 30.1. Canada Ribonucleic Acid (RNA) Editing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Ribonucleic Acid (RNA) Editing Market

  • 31.1. South America Ribonucleic Acid (RNA) Editing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Ribonucleic Acid (RNA) Editing Market

  • 32.1. Brazil Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Ribonucleic Acid (RNA) Editing Market

  • 33.1. Middle East Ribonucleic Acid (RNA) Editing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Ribonucleic Acid (RNA) Editing Market

  • 34.1. Africa Ribonucleic Acid (RNA) Editing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Ribonucleic Acid (RNA) Editing Market Regulatory and Investment Landscape

36. Ribonucleic Acid (RNA) Editing Market Competitive Landscape And Company Profiles

  • 36.1. Ribonucleic Acid (RNA) Editing Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Ribonucleic Acid (RNA) Editing Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Ribonucleic Acid (RNA) Editing Market Company Profiles
    • 36.3.1. Beam Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. EdiGene Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Deep Genomics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. ADARx Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Storm Therapeutics Limited Overview, Products and Services, Strategy and Financial Analysis

37. Ribonucleic Acid (RNA) Editing Market Other Major And Innovative Companies

  • Ascidian Therapeutics Inc., Korro Bio Inc., Shape TX

38. Global Ribonucleic Acid (RNA) Editing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Ribonucleic Acid (RNA) Editing Market

40. Ribonucleic Acid (RNA) Editing Market High Potential Countries, Segments and Strategies

  • 40.1 Ribonucleic Acid (RNA) Editing Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Ribonucleic Acid (RNA) Editing Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Ribonucleic Acid (RNA) Editing Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer